Gateway to Think Tanks
来源类型 | Report |
规范类型 | 报告 |
DOI | https://doi.org/10.7249/RR4445 |
来源ID | RR-4445-OSD |
Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit | |
Andrew W. Mulcahy; Brian Phillips; Christopher M. Whaley | |
发表日期 | 2021-01-14 |
出版年 | 2021 |
页码 | 24 |
语种 | 英语 |
结论 |
|
摘要 | The Military Health System provides health coverage — including prescription drug benefits — through the TRICARE program, which served an estimated 9.5 million beneficiaries in fiscal year 2018. Like commercial insurance and other sources of drug coverage, TRICARE uses formularies and other policies and tools to strike a balance between access to prescription drugs — in terms of which drugs are covered and where enrollees can receive drugs — and spending. Spending on prescription drugs typically increases as drug access becomes more generous. Unlike other sources of prescription drug coverage, TRICARE must also balance direct acquisition and distribution of drugs via military treatment facilities and mail-order pharmacies with payment for drugs dispensed in retail pharmacies. This report describes the TRICARE pharmacy benefit and the trade-offs in TRICARE pharmacy policies between increasing access and controlling costs. It presents six approaches that TRICARE should explore further to improve access, control costs, or both, including a more selective formulary, narrower pharmacy networks, and further harmonization with other federal purchasers, such as the Veterans Health Administration (VHA). These approaches are worth exploring in light of the recompetition of the TRICARE pharmacy contract and the ongoing consolidation of authority and management for purchased care under the Defense Health Agency. |
目录 |
|
主题 | Defense Health Agency ; Health Care Costs ; Pharmaceutical Drugs ; Prescription Drug Benefits ; Veterans Health Care |
URL | https://www.rand.org/pubs/research_reports/RR4445.html |
来源智库 | RAND Corporation (United States) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/524333 |
推荐引用方式 GB/T 7714 | Andrew W. Mulcahy,Brian Phillips,Christopher M. Whaley. Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit. 2021. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
RAND_RR4445.pdf(354KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
x1610628547938.jpg.p(4KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。